US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 34.000
  • -0.640-1.85%
Close Dec 11 16:00 ET
4.23BMarket Cap-16.75P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-12.28%396.86M
-41.57%360.09M
-57.40%325.92M
-36.36%351.19M
-36.36%351.19M
-36.15%452.41M
-27.74%616.26M
-20.74%765.08M
-21.23%551.8M
-21.23%551.8M
-Cash and cash equivalents
-12.28%396.86M
-41.57%360.09M
-57.40%325.92M
-36.36%351.19M
-36.36%351.19M
-22.56%452.41M
1.95%616.26M
20.78%765.08M
-13.81%551.8M
-13.81%551.8M
Receivables
51.86%283.97M
140.73%308.85M
764.42%272.34M
492.65%224.5M
492.65%224.5M
2,211.07%186.99M
1,606.56%128.3M
397.71%31.51M
274.94%37.88M
274.94%37.88M
-Accounts receivable
64.84%279.01M
174.48%304.43M
750.14%267.84M
2,571.70%206.44M
2,571.70%206.44M
1,991.93%169.26M
1,375.30%110.91M
397.71%31.51M
-23.52%7.73M
-23.52%7.73M
-Taxes receivable
----
----
----
--0
--0
--0
--0
----
--8.71M
--8.71M
-Other receivables
-72.04%4.96M
-74.59%4.42M
--4.5M
-15.80%18.05M
-15.80%18.05M
--17.73M
--17.39M
----
--21.44M
--21.44M
Inventory
22.85%121.06M
48.01%152.77M
88.67%161.28M
70.76%146.36M
70.76%146.36M
64.92%98.55M
113.03%103.22M
160.23%85.48M
426.30%85.71M
426.30%85.71M
Prepaid assets
-46.64%23.81M
-15.79%28.97M
18.06%43.16M
6.80%38.82M
6.80%38.82M
46.98%44.62M
60.18%34.4M
49.01%36.56M
46.17%36.35M
46.17%36.35M
Restricted cash
26.43%1.37M
23.41%1.34M
-13.49%1.1M
-12.49%1.11M
-12.49%1.11M
-13.74%1.09M
-14.30%1.09M
-18.16%1.28M
-18.55%1.27M
-18.55%1.27M
Other current assets
-47.97%6.82M
-15.59%7.95M
-77.82%7.62M
-33.07%4.35M
-33.07%4.35M
-45.18%13.12M
-66.89%9.42M
-53.21%34.35M
-90.80%6.51M
-90.80%6.51M
Total current assets
4.66%833.9M
-3.66%859.97M
-14.97%811.43M
6.51%766.33M
6.51%766.33M
-4.23%796.77M
-7.01%892.69M
-13.56%954.26M
-12.68%719.52M
-12.68%719.52M
Non current assets
Net PPE
0.81%20.44M
-8.65%20.16M
-19.45%19.19M
-15.28%21.09M
-15.28%21.09M
-19.56%20.27M
-17.20%22.07M
-7.90%23.82M
-4.54%24.9M
-4.54%24.9M
-Gross PPE
0.81%20.44M
-8.65%20.16M
-19.45%19.19M
-15.28%21.09M
-15.28%21.09M
-19.56%20.27M
-17.20%22.07M
-7.90%23.82M
-4.54%24.9M
-4.54%24.9M
Other non current assets
3,945.11%47.53M
2,844.50%24.35M
65.57%1.31M
-91.71%1.31M
-91.71%1.31M
-92.54%1.18M
-94.79%827K
-95.05%793K
-50.07%15.8M
-50.07%15.8M
Total non current assets
216.89%67.97M
94.43%44.51M
-16.71%20.5M
-44.96%22.4M
-44.96%22.4M
-47.63%21.45M
-46.17%22.89M
-41.22%24.61M
-29.50%40.69M
-29.50%40.69M
Total assets
10.22%901.87M
-1.21%904.48M
-15.01%831.93M
3.75%788.73M
3.75%788.73M
-6.26%818.22M
-8.67%915.58M
-14.57%978.87M
-13.78%760.22M
-13.78%760.22M
Liabilities
Current liabilities
Payables
134.88%42.73M
39.16%38.27M
-14.94%26.79M
0.47%37.52M
0.47%37.52M
29.03%18.19M
69.54%27.5M
156.61%31.49M
120.84%37.34M
120.84%37.34M
-accounts payable
134.88%42.73M
39.16%38.27M
-14.94%26.79M
0.47%37.52M
0.47%37.52M
29.03%18.19M
69.54%27.5M
156.61%31.49M
120.84%37.34M
120.84%37.34M
Current accrued expenses
-8.67%106.93M
2.42%100.08M
42.31%101.4M
34.34%127.81M
34.34%127.81M
46.77%117.09M
9.28%97.72M
-32.32%71.25M
-7.85%95.14M
-7.85%95.14M
Current provisions
--32.9M
--22.7M
----
----
----
----
----
----
----
----
Current debt and capital lease obligation
18.35%6.79M
6.19%6.21M
7.36%6.26M
14.51%6.44M
14.51%6.44M
5.83%5.74M
10.17%5.85M
27.81%5.83M
36.70%5.63M
36.70%5.63M
-Current capital lease obligation
18.35%6.79M
6.19%6.21M
7.36%6.26M
14.51%6.44M
14.51%6.44M
5.83%5.74M
10.17%5.85M
27.81%5.83M
36.70%5.63M
36.70%5.63M
Current deferred liabilities
--1.9M
--1.9M
--3.56M
----
----
----
----
----
----
----
Other current liabilities
----
----
157.02%77.29M
157.02%75.83M
157.02%75.83M
176.29%44.61M
176.28%43.77M
1,028.79%30.07M
289.03%29.5M
289.03%29.5M
Current liabilities
3.03%191.26M
-3.24%169.17M
55.28%215.29M
47.72%247.59M
47.72%247.59M
60.79%185.63M
37.89%174.84M
11.12%138.64M
27.12%167.61M
27.12%167.61M
Non current liabilities
Long term debt and capital lease obligation
346.52%463.66M
346.21%468.3M
-2.98%102.88M
-2.43%104.49M
-2.43%104.49M
-3.81%103.84M
-49.05%104.95M
-48.49%106.04M
-48.04%107.09M
-48.04%107.09M
-Long term debt
386.51%452.25M
392.24%457.21M
0.32%93.11M
0.32%93.03M
0.32%93.03M
0.32%92.96M
-50.94%92.88M
-50.94%92.81M
-50.94%92.74M
-50.94%92.74M
-Long term capital lease obligation
4.88%11.41M
-8.13%11.09M
-26.17%9.77M
-20.19%11.45M
-20.19%11.45M
-28.83%10.88M
-27.64%12.07M
-20.71%13.23M
-15.98%14.35M
-15.98%14.35M
Other non current liabilities
-96.68%9.83M
-99.07%2.69M
-23.28%247.08M
-23.29%242.13M
-23.29%242.13M
-13.33%296.48M
-13.39%290.39M
-8.76%322.06M
-8.55%315.65M
-8.55%315.65M
Total non current liabilities
18.28%473.49M
19.14%470.99M
-18.25%349.96M
-18.01%346.62M
-18.01%346.62M
-11.05%400.32M
-26.96%395.34M
-23.40%428.1M
-23.31%422.74M
-23.31%422.74M
Total liabilities
13.45%664.75M
12.27%640.16M
-0.26%565.25M
0.65%594.21M
0.65%594.21M
3.62%585.95M
-14.65%570.18M
-17.10%566.75M
-13.58%590.35M
-13.58%590.35M
Shareholders'equity
Share capital
0.00%12K
0.00%12K
0.00%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
10.00%11K
10.00%11K
-common stock
0.00%12K
0.00%12K
0.00%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
10.00%11K
10.00%11K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-9.10%-3B
-12.76%-2.94B
-16.78%-2.9B
-22.90%-2.84B
-22.90%-2.84B
-28.28%-2.75B
-33.67%-2.61B
-38.48%-2.49B
-39.37%-2.31B
-39.37%-2.31B
Paid-in capital
8.62%3.24B
8.61%3.21B
9.47%3.17B
22.42%3.04B
22.42%3.04B
21.56%2.98B
29.08%2.95B
28.30%2.9B
33.50%2.48B
33.50%2.48B
Gains losses not affecting retained earnings
-194.84%-3.14M
-322.36%-3.36M
-354.84%-3.53M
-304.80%-3.54M
-304.80%-3.54M
64.82%-1.07M
75.08%-796K
62.36%-775K
58.13%-875K
58.13%-875K
Total stockholders'equity
2.09%237.12M
-23.47%264.33M
-35.29%266.68M
14.51%194.52M
14.51%194.52M
-24.44%232.27M
3.28%345.4M
-10.84%412.12M
-14.49%169.87M
-14.49%169.87M
Total equity
2.09%237.12M
-23.47%264.33M
-35.29%266.68M
14.51%194.52M
14.51%194.52M
-24.44%232.27M
3.28%345.4M
-10.84%412.12M
-14.49%169.87M
-14.49%169.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -12.28%396.86M-41.57%360.09M-57.40%325.92M-36.36%351.19M-36.36%351.19M-36.15%452.41M-27.74%616.26M-20.74%765.08M-21.23%551.8M-21.23%551.8M
-Cash and cash equivalents -12.28%396.86M-41.57%360.09M-57.40%325.92M-36.36%351.19M-36.36%351.19M-22.56%452.41M1.95%616.26M20.78%765.08M-13.81%551.8M-13.81%551.8M
Receivables 51.86%283.97M140.73%308.85M764.42%272.34M492.65%224.5M492.65%224.5M2,211.07%186.99M1,606.56%128.3M397.71%31.51M274.94%37.88M274.94%37.88M
-Accounts receivable 64.84%279.01M174.48%304.43M750.14%267.84M2,571.70%206.44M2,571.70%206.44M1,991.93%169.26M1,375.30%110.91M397.71%31.51M-23.52%7.73M-23.52%7.73M
-Taxes receivable --------------0--0--0--0------8.71M--8.71M
-Other receivables -72.04%4.96M-74.59%4.42M--4.5M-15.80%18.05M-15.80%18.05M--17.73M--17.39M------21.44M--21.44M
Inventory 22.85%121.06M48.01%152.77M88.67%161.28M70.76%146.36M70.76%146.36M64.92%98.55M113.03%103.22M160.23%85.48M426.30%85.71M426.30%85.71M
Prepaid assets -46.64%23.81M-15.79%28.97M18.06%43.16M6.80%38.82M6.80%38.82M46.98%44.62M60.18%34.4M49.01%36.56M46.17%36.35M46.17%36.35M
Restricted cash 26.43%1.37M23.41%1.34M-13.49%1.1M-12.49%1.11M-12.49%1.11M-13.74%1.09M-14.30%1.09M-18.16%1.28M-18.55%1.27M-18.55%1.27M
Other current assets -47.97%6.82M-15.59%7.95M-77.82%7.62M-33.07%4.35M-33.07%4.35M-45.18%13.12M-66.89%9.42M-53.21%34.35M-90.80%6.51M-90.80%6.51M
Total current assets 4.66%833.9M-3.66%859.97M-14.97%811.43M6.51%766.33M6.51%766.33M-4.23%796.77M-7.01%892.69M-13.56%954.26M-12.68%719.52M-12.68%719.52M
Non current assets
Net PPE 0.81%20.44M-8.65%20.16M-19.45%19.19M-15.28%21.09M-15.28%21.09M-19.56%20.27M-17.20%22.07M-7.90%23.82M-4.54%24.9M-4.54%24.9M
-Gross PPE 0.81%20.44M-8.65%20.16M-19.45%19.19M-15.28%21.09M-15.28%21.09M-19.56%20.27M-17.20%22.07M-7.90%23.82M-4.54%24.9M-4.54%24.9M
Other non current assets 3,945.11%47.53M2,844.50%24.35M65.57%1.31M-91.71%1.31M-91.71%1.31M-92.54%1.18M-94.79%827K-95.05%793K-50.07%15.8M-50.07%15.8M
Total non current assets 216.89%67.97M94.43%44.51M-16.71%20.5M-44.96%22.4M-44.96%22.4M-47.63%21.45M-46.17%22.89M-41.22%24.61M-29.50%40.69M-29.50%40.69M
Total assets 10.22%901.87M-1.21%904.48M-15.01%831.93M3.75%788.73M3.75%788.73M-6.26%818.22M-8.67%915.58M-14.57%978.87M-13.78%760.22M-13.78%760.22M
Liabilities
Current liabilities
Payables 134.88%42.73M39.16%38.27M-14.94%26.79M0.47%37.52M0.47%37.52M29.03%18.19M69.54%27.5M156.61%31.49M120.84%37.34M120.84%37.34M
-accounts payable 134.88%42.73M39.16%38.27M-14.94%26.79M0.47%37.52M0.47%37.52M29.03%18.19M69.54%27.5M156.61%31.49M120.84%37.34M120.84%37.34M
Current accrued expenses -8.67%106.93M2.42%100.08M42.31%101.4M34.34%127.81M34.34%127.81M46.77%117.09M9.28%97.72M-32.32%71.25M-7.85%95.14M-7.85%95.14M
Current provisions --32.9M--22.7M--------------------------------
Current debt and capital lease obligation 18.35%6.79M6.19%6.21M7.36%6.26M14.51%6.44M14.51%6.44M5.83%5.74M10.17%5.85M27.81%5.83M36.70%5.63M36.70%5.63M
-Current capital lease obligation 18.35%6.79M6.19%6.21M7.36%6.26M14.51%6.44M14.51%6.44M5.83%5.74M10.17%5.85M27.81%5.83M36.70%5.63M36.70%5.63M
Current deferred liabilities --1.9M--1.9M--3.56M----------------------------
Other current liabilities --------157.02%77.29M157.02%75.83M157.02%75.83M176.29%44.61M176.28%43.77M1,028.79%30.07M289.03%29.5M289.03%29.5M
Current liabilities 3.03%191.26M-3.24%169.17M55.28%215.29M47.72%247.59M47.72%247.59M60.79%185.63M37.89%174.84M11.12%138.64M27.12%167.61M27.12%167.61M
Non current liabilities
Long term debt and capital lease obligation 346.52%463.66M346.21%468.3M-2.98%102.88M-2.43%104.49M-2.43%104.49M-3.81%103.84M-49.05%104.95M-48.49%106.04M-48.04%107.09M-48.04%107.09M
-Long term debt 386.51%452.25M392.24%457.21M0.32%93.11M0.32%93.03M0.32%93.03M0.32%92.96M-50.94%92.88M-50.94%92.81M-50.94%92.74M-50.94%92.74M
-Long term capital lease obligation 4.88%11.41M-8.13%11.09M-26.17%9.77M-20.19%11.45M-20.19%11.45M-28.83%10.88M-27.64%12.07M-20.71%13.23M-15.98%14.35M-15.98%14.35M
Other non current liabilities -96.68%9.83M-99.07%2.69M-23.28%247.08M-23.29%242.13M-23.29%242.13M-13.33%296.48M-13.39%290.39M-8.76%322.06M-8.55%315.65M-8.55%315.65M
Total non current liabilities 18.28%473.49M19.14%470.99M-18.25%349.96M-18.01%346.62M-18.01%346.62M-11.05%400.32M-26.96%395.34M-23.40%428.1M-23.31%422.74M-23.31%422.74M
Total liabilities 13.45%664.75M12.27%640.16M-0.26%565.25M0.65%594.21M0.65%594.21M3.62%585.95M-14.65%570.18M-17.10%566.75M-13.58%590.35M-13.58%590.35M
Shareholders'equity
Share capital 0.00%12K0.00%12K0.00%12K9.09%12K9.09%12K9.09%12K9.09%12K9.09%12K10.00%11K10.00%11K
-common stock 0.00%12K0.00%12K0.00%12K9.09%12K9.09%12K9.09%12K9.09%12K9.09%12K10.00%11K10.00%11K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -9.10%-3B-12.76%-2.94B-16.78%-2.9B-22.90%-2.84B-22.90%-2.84B-28.28%-2.75B-33.67%-2.61B-38.48%-2.49B-39.37%-2.31B-39.37%-2.31B
Paid-in capital 8.62%3.24B8.61%3.21B9.47%3.17B22.42%3.04B22.42%3.04B21.56%2.98B29.08%2.95B28.30%2.9B33.50%2.48B33.50%2.48B
Gains losses not affecting retained earnings -194.84%-3.14M-322.36%-3.36M-354.84%-3.53M-304.80%-3.54M-304.80%-3.54M64.82%-1.07M75.08%-796K62.36%-775K58.13%-875K58.13%-875K
Total stockholders'equity 2.09%237.12M-23.47%264.33M-35.29%266.68M14.51%194.52M14.51%194.52M-24.44%232.27M3.28%345.4M-10.84%412.12M-14.49%169.87M-14.49%169.87M
Total equity 2.09%237.12M-23.47%264.33M-35.29%266.68M14.51%194.52M14.51%194.52M-24.44%232.27M3.28%345.4M-10.84%412.12M-14.49%169.87M-14.49%169.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday-0.46%